Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
 
No Matching Results
Advanced search
or
Market: Market:
Menu

Ardelyx Inc (ARDX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Alerts
Watch
Help
Go To:
Ardelyx Reports Third Quarter 2018 Financial Results and Recent Highlights PR Newswire - Wed Nov 7, 3:05PM CST
CMTX - Wed Nov 7, 3:05PM CST

Ardelyx, Inc. (Nasdaq: ARDX), today reported business highlights and financial results for the third quarter ended September 30, 2018.

ARDX : 2.43 (-0.41%)
Analysis: Positioning to Benefit within Ardelyx, AXT, TG Therapeutics, MarineMax, Oclaro, and BioCryst Pharmaceuticals -- Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire - Tue Oct 16, 6:50AM CDT
CMTX - Tue Oct 16, 6:50AM CDT

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Ardelyx, Inc. (NASDAQ:ARDX),...

TGTX : 5.04 (-1.56%)
AXTI : 4.49 (-1.75%)
BCRX : 8.90 (-1.77%)
ARDX : 2.43 (-0.41%)
HZO : 19.75 (-1.25%)
OCLR : 8.26 (-2.13%)
Ardelyx Showcases New Data from T3MPO-3 Long-Term Safety Trial of Tenapanor for IBS-C in Presidential Poster at ACG 2018 Annual Meeting PR Newswire - Mon Oct 8, 7:01AM CDT
CMTX - Mon Oct 8, 7:01AM CDT

Ardelyx, Inc. (Nasdaq: ARDX), today announced that new data from its long-term safety trial of tenapanor for irritable bowel syndrome with constipation (IBS-C), the T3MPO-3 trial, were presented this weekend...

ARDX : 2.43 (-0.41%)
Ardelyx to Host Its First Annual Investor Day Focused on Treatment Landscape of Renal Disorders PR Newswire - Thu Oct 4, 5:30AM CDT
CMTX - Thu Oct 4, 5:30AM CDT

Ardelyx, Inc. (Nasdaq: ARDX), today announced that it will hold an investor event called "Renal Day" on Thursday, Oct. 11, 2018, from 8 to 10 a.m. ET in New York City. This year's event is the first of...

ARDX : 2.43 (-0.41%)
Ardelyx Submits New Drug Application for U.S. Marketing Authorization of Tenapanor for IBS-C to U.S. Food and Drug Administration PR Newswire - Thu Sep 13, 5:30AM CDT
CMTX - Thu Sep 13, 5:30AM CDT

Ardelyx, Inc. (Nasdaq: ARDX), today announced the submission of its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) requesting U.S. marketing authorization of tenapanor for the...

ARDX : 2.43 (-0.41%)
Bruce Walton Named President and COO of Aurora Diagnostics BusinessWire - Fri May 11, 8:00AM CDT
CMTX - Fri May 11, 8:00AM CDT

Aurora Diagnostics announced today that Bruce Walton, the company's Executive Vice President and Chief Operating Officer (COO) since January 2015, has been promoted to President and COO.

ARDX : 2.43 (-0.41%)
Ardelyx Reports First Quarter 2018 Financial Results and Recent Business Highlights PR Newswire - Tue May 8, 3:05PM CDT
CMTX - Tue May 8, 3:05PM CDT

Ardelyx, Inc. (NASDAQ: ARDX), today reported business highlights and financial results for the first quarter ended March 31, 2018.

ARDX : 2.43 (-0.41%)
Ardelyx Inc Down 12.1% Since SmarTrend Downtrend Call (ARDX) Comtex SmarTrend(R) - Wed May 2, 12:29AM CDT
CMTX - Wed May 2, 12:29AM CDT

SmarTrend identified a Downtrend for Ardelyx Inc (NASDAQ:ARDX) on February 13th, 2018 at $5.69. In approximately 3 months, Ardelyx Inc has returned 12.13% as of today's recent price of $5.00.

ARDX : 2.43 (-0.41%)
Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (ARDX , SGMO , FMI , INSY , KPTI ) Comtex SmarTrend(R) - Wed Apr 18, 3:20AM CDT
CMTX - Wed Apr 18, 3:20AM CDT

Below are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the...

SGMO : 11.74 (+0.51%)
FMI : 136.95 (-0.04%)
ARDX : 2.43 (-0.41%)
Cascade Pathology Services Practice Joins Aurora Diagnostics BusinessWire - Mon Apr 9, 4:00PM CDT
CMTX - Mon Apr 9, 4:00PM CDT

Aurora Diagnostics announced today that Cascade Pathology Services Corp., a physician-owned multi-specialty pathology practice providing surgical pathology services to hospitals and physician...

ARDX : 2.43 (-0.41%)
Analysis: Positioning to Benefit within Euronet Worldwide, Innospec, Zosano Pharma, Ardelyx, Crown Castle International, and Aldeyra Therapeutics -- Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire - Thu Apr 5, 7:15AM CDT
CMTX - Thu Apr 5, 7:15AM CDT

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Euronet Worldwide, Inc. (NASDAQ:EEFT),...

IOSP : 66.07 (-0.11%)
ALDX : 9.49 (+1.71%)
CCI : 116.14 (+0.03%)
ARDX : 2.43 (-0.41%)
ZSAN : 3.70 (+2.78%)
EEFT : 113.17 (+0.26%)
Knight Announces Exclusive License Agreement with Ardelyx for Tenapanor Marketwire - Mon Mar 19, 5:30AM CDT
CMTX - Mon Mar 19, 5:30AM CDT

Agreement Advances First-in-Class Tenapanor for IBS-C and Hyperphosphatemia in Canada Ardelyx to Receive Up to CAD 25 Million in Upfront Payment and Subsequent Milestones

GUD.TO : 8.43 (-1.17%)
ARDX : 2.43 (-0.41%)
Ardelyx and Knight Collaborate to Bring Tenapanor to Patients in Canada PR Newswire - Mon Mar 19, 5:30AM CDT
CMTX - Mon Mar 19, 5:30AM CDT

Ardelyx, Inc. (NASDAQ: ARDX) today announced a license agreement with Knight Therapeutics, Inc. (TSX: GUD) (Knight) that provides Knight with exclusive rights to commercialize tenapanor in Canada. Tenapanor...

GUD.TO : 8.43 (-1.17%)
ARDX : 2.43 (-0.41%)
Ardelyx Reports 2017 Financial Results and Appoints Industry Veteran, Jan Lundberg, Ph.D., to Board of Directors PR Newswire - Wed Mar 14, 3:05PM CDT
CMTX - Wed Mar 14, 3:05PM CDT

Ardelyx, Inc. (NASDAQ: ARDX), today reported pipeline highlights and financial results for the fourth quarter and full-year ended December 31, 2017. In addition, industry-leading research expert, Jan M....

ARDX : 2.43 (-0.41%)
Consolidated Research: 2018 Summary Expectations for Progress Software, Cracker Barrel Old Country Store, Natural Grocers by Vitamin Cottage, VBI Vaccines, Ardelyx, and CytomX Therapeutics -- Fundamental Analysis, Key Performance Indications GlobeNewswire - Mon Feb 26, 7:20AM CST
CMTX - Mon Feb 26, 7:20AM CST

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Progress Software Corporation...

VBIV : 1.55 (+14.81%)
NGVC : 18.00 (+4.17%)
CTMX : 14.52 (+0.69%)
CBRL : 172.50 (-1.07%)
PRGS : 34.52 (-0.12%)
ARDX : 2.43 (-0.41%)

Van Meerten Stock Picks

Tesla According to Peter Lynch
Today's Barchart Chart of the Day will be the auto maker Tesla (TSLA).
Tue Sep 18, 10:26AM CDT
TSLA +1.61
See More
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.
Free Commodities Newsletter

Get prepared for your trading day with

Barchart's Commodity Futures Morning Update Email

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

cmdty Insider - Ag Market Commentary

Today's Commentary

Corn futures closed the Tuesday session with most contracts fractionally to 1 3/4 cents higher, despite larger carryout estimates for both the US and World. USDA updated their monthly S&D table this morning showing no change to the production side fo...
Read More

1 hour ago

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
Reserve Your Spot